CDC’s Investments to Combat Antibiotic Resistance Threats: AR & COVID-19 Funding Help Stop the Spread of Emerging Threats: Fiscal Year 2022 Sampling of Shared Activities

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Many of the nation’s efforts to prevent the spread of SARS-CoV-2 will also help in the fight against antimicrobial resistance, including investments in IPC, training, surveillance, and public health personnel. The following represent many of those shared CDC public health activities funded by COVID-19 supplemental appropriations, such as the American Rescue Plan Act or the CARES Act.
  
  Publication date from document properties.
  
  ARfundingHelpsCovid.pdf
  
  
• Subjects:
  Antimicrobial Stewardship Communicable Diseases, Emerging COVID-19/prevention & Control Cross Infection/prevention & Control Drug Resistance, Microbial Financing, Government Food Safety Local Government Public Health State Government
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  United States
• Pages in Document:
  9 numbered pages
• Federal Fiscal Year:
  2022
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:db7ba0eff8cb36476c1112e1e71dff0e096304aade2943b55bdc33d62167552fefa755800bc993b50bd85ff1a8885edc65bbd111ecbb03fbd42df1bc449fbbaa
• Download URL:
  https://stacks.cdc.gov/view/cdc/129034/cdc_129034_DS1.pdf
• File Type:
  [PDF - 2.59 MB ]